Prelude Therapeutics (PRLD)
NASDAQ: PRLD
· Real-Time Price · USD
0.84
-0.10 (-11.11%)
At close: Aug 15, 2025, 3:59 PM
0.87
4.05%
After-hours: Aug 15, 2025, 04:54 PM EDT
Prelude Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 4M | 3M | n/a | n/a | 3.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 331K | 279K | 723K | 710K | 799K | 776K | 749K | 718K | 690K | 622K | 489K | 442K |
Gross Profit | n/a | 4M | 3M | n/a | n/a | 3.09M | -279K | -723K | -710K | -799K | -776K | -749K | -718K | -690K | -622K | -489K | -442K |
Operating Income | -34.61M | -33.83M | -34.38M | -37.16M | -34.34M | -37.38M | -33.38M | -32.4M | -29.11M | -33.38M | -30.41M | -29.46M | -30.29M | -33.01M | -30.84M | -27.92M | -21.97M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -32.09M | -28.73M | -32.27M | -34.74M | -31.43M | -33.08M | -30.61M | -30.43M | -27.72M | -28.64M | -29.96M | -27.37M | -29.46M | -32.84M | -30.69M | -26.86M | -21.3M |
Net Income | -32.09M | -28.73M | -32.27M | -34.74M | -31.43M | -33.08M | -30.61M | -30.43M | -26.32M | -20.99M | -29.51M | -25.29M | -28.64M | -32.84M | -30.69M | -26.86M | -21.3M |
Selling & General & Admin | 5.79M | 6.21M | 7.92M | 7.66M | 6.93M | 7.05M | 7.12M | 7.43M | 7.28M | 7.52M | 7.52M | 8.15M | 7.47M | 7.83M | 8.12M | 5.51M | 5.5M |
Research & Development | 28.82M | 31.62M | 29.46M | 29.51M | 27.41M | 30.33M | 26.26M | 24.97M | 21.83M | 25.87M | 22.89M | 21.31M | 22.82M | 25.18M | 22.72M | 22.41M | 16.47M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.97M | 1.4M | 4.74M | 448K | 2.09M | 823K | 168K | 149K | 1.06M | 667K |
Operating Expenses | 34.61M | 37.83M | 37.38M | 37.16M | 34.34M | 37.38M | 33.38M | 32.4M | 29.11M | 33.38M | 30.41M | 29.46M | 30.29M | 33.01M | 30.84M | 27.92M | 21.97M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1.4M | n/a | n/a | n/a | 2.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 34.61M | 37.83M | 37.38M | 37.16M | 34.34M | 37.38M | 33.38M | 32.4M | 29.11M | 33.38M | 30.41M | 29.46M | 30.29M | 33.01M | 30.84M | 27.92M | 21.97M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -279K | 239.42K | -1.4M | -7.65M | -448K | -2.09M | -823K | -168K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 75.99M | 75.9M | 75.86M | 75.76M | 75.74M | 69.59M | 67.64M | 56.24M | 47.74M | 47.9M | 47.45M | 47.28M | 47.07M | 46.33M | 46.33M | 46.06M | 45.12M |
Shares Outstanding (Diluted) | 75.99M | 75.9M | 75.86M | 75.76M | 75.74M | 69.59M | 67.64M | 56.24M | 47.74M | 47.9M | 47.45M | 47.28M | 47.07M | 46.33M | 46.33M | 46.06M | 45.12M |
EPS (Basic) | -0.42 | -0.38 | -0.43 | -0.46 | -0.42 | -0.48 | -0.45 | -0.54 | -0.55 | -0.44 | -0.62 | -0.53 | -0.61 | -0.71 | -0.66 | -0.58 | -0.47 |
EPS (Diluted) | -0.42 | -0.38 | -0.43 | -0.46 | -0.42 | -0.48 | -0.45 | -0.54 | -0.55 | -0.44 | -0.62 | -0.53 | -0.61 | -0.71 | -0.66 | -0.58 | -0.47 |
EBITDA | -34.17M | -33.34M | -33.97M | -36.71M | -33.92M | -37.05M | -33.11M | -32.12M | -28.84M | -33.02M | -30.07M | -29.14M | -29.98M | -32.72M | -30.57M | -27.72M | -21.81M |
EBIT | -34.61M | -33.83M | -34.38M | -37.16M | -34.34M | -37.38M | -33.38M | -32.4M | -29.11M | -33.38M | -30.41M | -29.46M | -30.29M | -33.01M | -30.84M | -27.92M | -21.97M |
Depreciation & Amortization | 435K | 489K | 405K | 452K | 426K | 331K | 279K | 723K | 710K | 799K | 776K | 749K | 718K | 690K | 622K | 489K | 442K |